» Articles » PMID: 25459585

Anaphylaxis and Urticaria

Overview
Date 2014 Dec 3
PMID 25459585
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Anaphylaxis and urticaria are common presenting allergic complaints. Affecting up to 2% of the population, anaphylaxis is a serious, life-threatening allergic reaction. Although not life-threatening, urticaria is a rash of transient, erythematous, pruritic wheals that can be bothersome and affects up to 25% of the population. All cases of anaphylaxis warrant thorough clinical evaluation by the allergist-immunologist, although most cases of urticaria are self-limited and do not require specialist referral. This article offers an overview of our current knowledge on the epidemiology, pathogenesis, triggers, diagnosis, and treatment of anaphylaxis and urticaria.

Citing Articles

Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial.

Spicer J, Basu B, Montes A, Banerji U, Kristeleit R, Miller R Nat Commun. 2023; 14(1):4180.

PMID: 37491373 PMC: 10368744. DOI: 10.1038/s41467-023-39679-9.


An Updated Overview of Almond Allergens.

Bezerra M, Ribeiro M, Igrejas G Nutrients. 2021; 13(8).

PMID: 34444737 PMC: 8399460. DOI: 10.3390/nu13082578.


Imidazolidinyl urea activates mast cells via MRGPRX2 to induce non-histaminergic allergy.

Gao J, Che D, Du X, Zheng Y, Jing H, Wang N Toxicol Res (Camb). 2021; 10(3):467-475.

PMID: 34141160 PMC: 8201555. DOI: 10.1093/toxres/tfab035.


Fixed drug eruption and anaphylaxis induced concurrently by erdosteine: a case report.

Sim D, Yu J, Koh Y Allergy Asthma Clin Immunol. 2021; 17(1):15.

PMID: 33546741 PMC: 7866636. DOI: 10.1186/s13223-021-00517-6.


An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

Chen C, Abe R, Pan R, Wang C, Hung S, Tsai Y J Immunol Res. 2018; 2018:6431694.

PMID: 29651444 PMC: 5830968. DOI: 10.1155/2018/6431694.